Related Experiment Video
Updated: Feb 2, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
[Advances in the treatment of juvenile myelomonocytic leukemia]
Yu-Li Cai1, Jing-Liao Zhang, Xiao-Fan Zhu
1Department of Pediatrics, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin 300020, China. lily4e09@163.com.
Insights
Juvenile myelomonocytic leukemia (JMML) is a rare pediatric cancer. Current treatments like chemotherapy are ineffective, but stem cell transplant offers a cure, with new targeted therapies showing promise.
Area of Science:
- Pediatric Hematology Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Juvenile myelomonocytic leukemia (JMML) is a rare, aggressive childhood myeloid malignancy.
- JMML exhibits features of both myelodysplastic and myeloproliferative neoplasms.
- Conventional chemotherapy shows limited efficacy in treating JMML.
Purpose of the Study:
- To review current treatment strategies for JMML.
- To evaluate the efficacy of emerging therapies for JMML.
- To provide an overview of JMML management and outcomes.
Main Methods:
- Review of existing literature on JMML treatments.
- Analysis of data on targeted therapies and demethylation treatments.
- Evaluation of hematopoietic stem cell transplantation as a curative option.
Main Results:
- Hematopoietic stem cell transplantation remains the only potential cure for JMML.
- Targeted therapies for Ras signaling pathway mutations show progress.
- Demethylation treatments for aberrant methylation are under investigation.
Conclusions:
- JMML is a challenging pediatric leukemia with poor response to standard chemotherapy.
- Advances in targeted and epigenetic therapies offer new hope for JMML patients.
- Further research is crucial for improving JMML treatment outcomes.
Abstract:
Juvenile myelomonocytic leukemia (JMML) is a rare chronic myeloid leukemia in children and has the features of both myelodysplastic syndrome and myeloproliferative neoplasm. It is highly malignant and has a poor treatment outcome. Children with JMML have a poor response to conventional chemotherapy. At present, hematopoietic stem cell transplantation is the only possible cure for this disease. In recent years, significant progress has been made in targeted therapy for mutant genes in the Ras signaling pathway and demethylation treatment of aberrant methylation of polygenic CpG islands. This article reviews the treatment and efficacy evaluation of JMML.
Related Concept Videos
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers

